<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17609</article-id><article-id pub-id-type="doi">10.15789/2220-7619-ACB-17609</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Assessed correlation between biological diversity of oropharyngeal microbiota and atopic dermatitis severity and exacerbations</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка корреляции биологического разнообразия микробиоты ротоглотки со степенью тяжести и частотой обострений у пациентов с атопическим дерматитом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pobezhimova</surname><given-names>O. O.</given-names></name><name xml:lang="ru"><surname>Побежимова</surname><given-names>О. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Senior Laboratory Technician, Department of General and Clinical Microbiology, Immunology and Allergology</p></bio><bio xml:lang="ru"><p>старший лаборант кафедры общей и клинической микробиологии, иммунологии и аллергологии</p></bio><email>a.v.lyamin@samsmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhestkov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Жестков</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Honored Worker of Science of the Russian Federation, DSc (Medicine), Professor, Head of the Department of General and Clinical Microbiology, Immunology and Allergology</p></bio><bio xml:lang="ru"><p>заслуженный деятель науки РФ, д.м.н., профессор, зав. кафедрой общей и клинической микробиологии, иммунологии и аллергологии</p></bio><email>a.v.lyamin@samsmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lyamin</surname><given-names>Artem V.</given-names></name><name xml:lang="ru"><surname>Лямин</surname><given-names>Артем Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Associate Professor, Professor of the Department of General and Clinical Microbiology, Immunology and Allergology</p></bio><bio xml:lang="ru"><p>д.м.н., доцент, профессор кафедры общей и клинической микробиологии, иммунологии и аллергологии</p></bio><email>a.v.lyamin@samsmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Reshetnikova</surname><given-names>V. P.</given-names></name><name xml:lang="ru"><surname>Решетникова</surname><given-names>В. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of General and Clinical Microbiology, Immunology and Allergology</p></bio><bio xml:lang="ru"><p>к.м.н., доцент, доцент кафедры общей и клинической микробиологии, иммунологии и аллергологии</p></bio><email>a.v.lyamin@samsmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ereshchenko</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Ерещенко</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Assistant Professor, Department of Fundamental and Clinical Biochemistry with Laboratory Diagnostics</p></bio><bio xml:lang="ru"><p>к.м.н., ассистент кафедры фундаментальной и клинической биохимии с лабораторной диагностикой</p></bio><email>a.v.lyamin@samsmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Alekseev</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Алексеев</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Student</p></bio><bio xml:lang="ru"><p>студент</p></bio><email>a.v.lyamin@samsmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Samara State Medical University of Ministry of Healthсare of Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Самарский государственный медицинский университет Минздрава России</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-08-13" publication-format="electronic"><day>13</day><month>08</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-10-31" publication-format="electronic"><day>31</day><month>10</month><year>2024</year></pub-date><volume>14</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>701</fpage><lpage>708</lpage><history><date date-type="received" iso-8601-date="2024-02-24"><day>24</day><month>02</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-08-08"><day>08</day><month>08</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Pobezhimova O.O., Zhestkov A.V., Lyamin A.V., Reshetnikova V.P., Ereshchenko A.A., Alekseev D.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Побежимова О.О., Жестков А.В., Лямин А.В., Решетникова В.П., Ерещенко А.А., Алексеев Д.В.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Pobezhimova O.O., Zhestkov A.V., Lyamin A.V., Reshetnikova V.P., Ereshchenko A.A., Alekseev D.V.</copyright-holder><copyright-holder xml:lang="ru">Побежимова О.О., Жестков А.В., Лямин А.В., Решетникова В.П., Ерещенко А.А., Алексеев Д.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/17609">https://iimmun.ru/iimm/article/view/17609</self-uri><abstract xml:lang="en"><p>Atopic dermatitis (AtD) is a multifactorial inflammatory skin disease characterized by itching, chronic recurrent course and age-related features of lesions. AtD pathogenesis has not been fully elucidated yet. An important factor for AtD emergence and progression is the imbalance in symbiotic microbiota. The research publications provide a few studies about a role for oropharyngeal microorganisms in AtD immunopathogenesis. The aim of the study is to analyze biological diversity of oropharyngeal microbial communities in varying AtD severity. 97 male patients, aged from 16 to 19 years, with different AtD severity were included in the study. Culture study of oropharyngeal discharge was also performed. Biological material was seeded on the expanded list of growth media and incubated for 5 days at the 37°С. To assess the biological diversity of the oropharyngeal microbiota, the coefficient of constancy (C) was used, in order to classify individual microorganisms as permanent, additional or transient. Statistical data processing was performed using the Stat Tech software (version 4.0.0, Stattech LLC, Russia). While examining biological diversity of the oropharyngeal microbiota in AtD patients, 58 microbial species were isolated and identified. After statistical analysis the significant differences in frequency of isolation, depending on different AtD severity were observed for microbes such as <italic>Streptococcus vestibularis</italic> and <italic>Rothia dentocariosa</italic>. When <italic>R. dentocariosa</italic> is isolated from the oropharynx, the chances of AtD exacerbation emergence decreased by 6 times, whereas in case of <italic>S. vestibularis</italic>, on the contrary, it increased by 5 times. Therefore, identification of transitions of individual microbes from transient to additional and permanent microbiota and vice versa, depending on the AtD stage and severity, allows to analyze an influence of specific microorganisms in AtD pathological processes and to establish definite new microbiological predictors of AtD exacerbation and remission.</p></abstract><trans-abstract xml:lang="ru"><p>Атопический дерматит (АтД) — многофакторное воспалительное заболевание кожи, характеризующееся зудом, хроническим рецидивирующим течением и различными возрастными особенностями. Патогенез АтД еще полностью не выяснен. Важным фактором возникновения и прогрессирования АтД является дисбаланс симбиотической микробиоты. Научная литература содержит небольшое количество информации об участии микроорганизмов ротоглотки в иммунопатогенезе АтД. Цель исследования — провести анализ биологического разнообразия микробных сообществ ротоглотки в группах пациентов с различной степенью тяжести АтД и на разных стадиях АтД (ремиссия/обострение). В исследование были включены 97 пациентов с различной степенью тяжести АтД. Также было проведено культуральное исследование выделений из ротоглотки. Посев материала проводили на расширенный перечень питательных сред и инкубировали при температуре 37°С в течение 5 суток. Для оценки биологического разнообразия микробиоты ротоглотки использовался коэффициент постоянства (C), позволяющий классифицировать отдельные микроорганизмы как постоянные, дополнительные или временные. Статистические расчеты проводились с использованием программного обеспечения StatTech (версия 4.0.0, разработчик ООО «Статтех», Россия). В ходе исследования у включенных в него пациентов было выделено и идентифицировано 58 видов микроорганизмов. В ходе статистического анализа были получены значимые различия в частоте выделения, в зависимости от различной степени тяжести АтД, для таких микроорганизмов, как <italic>Streptococcus vestibularis</italic> и <italic>Rothia dentocariosa</italic>. При выделении <italic>R. dentocariosa</italic> из ротоглотки вероятность возникновения обострения АтД снижалась в 6 раз. При выделении <italic>S. vestibularis</italic> вероятность возникновения обострения АтД, в отличие от <italic>R. dentocariosa</italic>, увеличивалась в 5 раз. Таким образом, выявление переходов отдельных микроорганизмов от транзиторной к дополнительной и постоянной микробиоте и наоборот, в зависимости от стадии и тяжести АтД, позволяет нам проанализировать влияние определенных микроорганизмов на патологические процессы при АтД и установить предпосылки для открытия новых микробиологические предикторов обострения и ремиссии АтД.</p></trans-abstract><kwd-group xml:lang="en"><kwd>atopic dermatitis</kwd><kwd>oropharyngeal microbiota</kwd><kwd>biological diversity</kwd><kwd>skin diseases</kwd><kwd>immunological disorders</kwd><kwd>microbiome</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атопический дерматит</kwd><kwd>микробиота ротоглотки</kwd><kwd>биологическое разнообразие</kwd><kwd>кожные болезни</kwd><kwd>иммунологические нарушения</kwd><kwd>микробиом</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Гончаров А.Г., Продеус А.П., Шевченко М.А., Мархайчук А.З., Разина А.С., Гончарова Е.А., Маляров А.М., Русина Е.В. Роль микробиоты в патофизиологических механизмах формирования аллергического ринита: обзор // Вестник Балтийского федерального университета им. И. Канта. Серия: Естественные и медицинские науки. 2020. № 3. С. 100–121. [Goncharov A.G., Prodeus A.P., Shevchenko M.A., Markhaichuk A.Z., Razina A.S., Goncharova E.A., Malyarov A.M., Rusina E.V. Role of Microbiota in Pathophysiological Mechanisms of Emergence of Allergic Rhinitis. Vestnik Baltijskogo Federal’nogo Universiteta im. I. Kanta. Serija: estestvennye i medicinskie nauki = Bulletin of the I. Kant Baltic Federal University. Series: Natural and Medical Sciences, 2013, no. 3, pp. 100–121. (In Russ.)]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Жестков А.В., Лямин А.В., Побежимова О.О. Оценка культурома отделяемого верхних дыхательных путей и содержимого толстой кишки у пациентов с атопическим дерматитом // Вестник современной клинической медицины. 2022. Т. 15, № 1. С. 17–25. [Zhestkov A.V., Lyamin A.V., Pobezhimova O.O. Evaluation of the culturoma of the discharge of the upper respiratory tract and the contents of the colon in patients with atopic dermatitis. Vestnik sovremennoi klinicheskoi meditsiny = The Bulletin of Contemporary Clinical Medicine, 2022, vol. 15, no. 1, pp. 17–25. (In Russ.)] doi: 10.20969/VSKM.2022.15(1).17-25</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Побежимова О.О., Жестков А.В., Сидорова О.С., Кулагина В.В. Особенности иммунопатогенеза атопического дерматита // Российский аллергологический журнал. 2020. Т. 17, № 2. C. 74–80. [Pobezhimova O.O., Zhestkov A.V., Sidorova O.S., Kulagina V.V. Features of immunopathogenesis of atopic dermatitis. Rossiyskiy allergologicheskiy zhurnal = Russian Journal of Allergy, 2020, vol. 17, no. 2, pp. 74–80. (In Russ.)] doi: 10.36691/RJA1357</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Репецкая М.Н., Маслов Ю.Н., Шайдуллина Е.В., Бурдина О.М. Микробиоценоз кожи и слизистых при атопическом дерматите у детей // Журнал микробиологии, эпидемиологии и иммунобиологии. 2014. Т. 91, № 6. C. 112–116. [Repetskaya M.N., Maslov Y.N., Shaidullina E.V., Burdina O.M. Skin and mucous membrane microbiocenosis during atopic dermatitis in children. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2014, vol. 91, no. 6, pp. 112–116. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Aggor F.E.Y., Bertolini M., Zhou C., Taylor T.C., Abbott D.A., Musgrove J. A gut-oral microbiome-driven axis controls oropharyngeal candidiasis through retinoic acid. JCI Insight, 2022, vol. 7, no. 18: e160348. doi: 10.1172/jci.insight.160348.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Al Kindi A., Williams H., Matsuda K., Alkahtani A.M., Saville C., Bennett H., Alshammari Y., Tan S.Y., O’Neill C., Tanaka A., Matsuda H., Arkwright P.D., Pennock J.L. Staphylococcus aureus second immunoglobulin-binding protein drives atopic dermatitis via IL-33. J. Allergy Clin. Immunol., 2021, vol. 147, no. 4, pp. 1354–1368. doi: 10.1016/j.jaci.2020.09.023</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Alsterholm M., Strömbeck L., Ljung A., Karami N., Widjestam J., Gillstedt M., Åhren C., Faergemann J. Variation in Staphylococcus aureus colonization in relation to disease severity in adults with atopic dermatitis during a five-month follow-up. Acta Derm. Venereol., 2017, vol. 97, no. 7, pp. 802–807. doi: 10.2340/00015555-2667</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Beheshti R., Halstead S., McKeone D., Hicks S.D. Understanding immunological origins of atopic dermatitis through multi-omic analysis. Pediatr. Allergy Immunol., 2022, vol. 33, no. 6: e13817. doi: 10.1111/pai.13817</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bellussi L.M., Passali F.M., Ralli M., De Vincentiis M., Greco A., Passali D. An overview on upper respiratory tract infections and bacteriotherapy as innovative therapeutic strategy. Eur. Rev. Med. Pharmacol. Sci., 2019, vol. 23, no. 1, pp. 27–38. doi: 10.26355/eurrev_201903_17345</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bertolini M., Costa R.C., Barão V.A.R., Cunha Villar C., Retamal-Valdes B., Feres M., Silva Souza J.G. Oral microorganisms and biofilms: new insights to defeat the main etiologic factor of oral diseases. Microorganisms, 2022, vol. 10, no. 12: 2413. doi: 10.3390/microorganisms10122413</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bonzano L., Borgia F., Casella R., Miniello A., Nettis E., Gangemi S. Microbiota and IL-33/31 axis linkage: implications and therapeutic perspectives in atopic dermatitis and psoriasis. Biomolecules, 2023, vol. 13, no. 7: 1100. doi: 10.3390/biom13071100</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Edslev S.M., Agner T., Andersen P.S. Skin microbiome in atopic dermatitis. Acta Derm. Venereol., 2020, vol. 100, no. 12: adv00164. doi: 10.2340/00015555-3514</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Facheris P., Jeffery J., Del Duca E., Guttman-Yassky E. The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. Cell. Mol. Immunol., 2023, vol. 20, no. 5, pp. 448–474. doi: 10.1038/s41423-023-00992-4</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Fadlallah J., El Kafsi H., Sterlin D., Juste C., Parizot C., Dorgham K., Autaa G., Gouas D., Almeida M., Lepage P., Pons N., Le Chatelier E., Levenez F., Kennedy S., Galleron N., de Barros J.P., Malphettes M., Galicier L., Boutboul D., Mathian A., Miyara M., Oksenhendler E., Amoura Z., Doré J., Fieschi C., Ehrlich S.D., Larsen M., Gorochov G. Microbial ecology perturbation in human IgA deficiency. Sci. Transl. Med., 2018, vol. 10, no. 439: eaan1217. doi: 10.1126/scitranslmed.aan1217</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Fang Z., Li L., Zhang H., Zhao J., Lu W., Chen W. Gut Microbiota, probiotics, and their interactions in prevention and treatment of atopic dermatitis: a review. Front. Immunol., 2021, no. 12: 720393. doi: 10.3389/fimmu.2021.720393</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Hanson B.M., Kates A.E., O’Malley S.M., Mills E., Herwaldt L.A., Torner J.C., Dawson J.D., Farina S.A., Klostermann C., Wu J.Y., Quick M.K., Forshey B.M., Smith T.C. Staphylococcus aureus in the nose and throat of Iowan families. Epidemiol. Infect., 2018, vol. 146, no. 14, pp. 1777–1784. doi: 10.1017/S0950268818001644</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hrestak D., Matijašić M., Čipčić Paljetak H., Ledić Drvar D., Ljubojević Hadžavdić S., Perić M. Skin Microbiota in Atopic Dermatitis. Int. J. Mol. Sci., 2022, vol. 23, no. 7: 3503. doi: 10.3390/ijms23073503</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Kang M.J., Lee S.Y., Park Y.M., Kim B.S., Lee M.J., Kim J.H., Jeong S., Lee S.H., Park M.J., Rhee E.S., Jung S., Yoon J., Cho H.J., Lee E., Yang S.I., Suh D.I., Kim K.W., Sheen Y.H., Ahn K., Hong S.J. Interactions Between IL-17 Variants and Streptococcus in the Gut Contribute to the Development of Atopic Dermatitis in Infancy. Allergy Asthma Immunol. Res., 2021, vol. 13, no. 3, pp. 404–419. doi: 10.4168/aair.2021.13.3.404</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Katoh N., Ohya Y., Ikeda M., Ebihara T., Katayama I., Saeki H., Shimojo N., Tanaka A., Nakahara T., Nagao M., Hide M., Fujita Y., Fujisawa T., Futamura M., Masuda K., Murota H., Yamamoto-Hanada K.; Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis 2018, The Japanese Society of Allergology, The Japanese Dermatology Association. Japanese guidelines for atopic dermatitis 2020. Allergol. Int., 2020, vol. 69, no. 3, pp. 356–369. doi: 10.1016/j.alit.2020.02.006</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Laughter M.R., Maymone M.B.C., Mashayekhi S., Arents B.W.M., Karimkhani C., Langan S.M., Dellavalle R.P., Flohr C. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017. Br. J. Dermatol., 2021, vol. 184, no. 2, pp. 304–309. doi: 10.1111/bjd.19580</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Losol P., Park H.S., Song W.J., Hwang Y.K., Kim S.H., Holloway J.W., Chang Y.S. Association of upper airway bacterial microbiota and asthma: systematic review. Asia Pac. Allergy, 2022, vol. 12, no. 3: e32. doi: 10.5415/apallergy.2022.12.e32</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Makowska K., Nowaczyk J., Blicharz L., Waśkiel-Burnat A., Czuwara J., Olszewska M., Rudnicka L. Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments. Int. J. Mol. Sci., 2023, vol. 24, no. 1: 781. doi: 10.3390/ijms24010781</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Mohammad S., Karim M.R., Iqbal S., Lee J.H., Mathiyalagan R., Kim Y.J., Yang D.U., Yang D.C. Atopic dermatitis: Pathophysiology, microbiota, and metabolome — a comprehensive review. Microbiol. Res., 2024, no. 281: 127595. doi: 10.1016/j.micres.2023.127595</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Nakashima C., Yanagihara S., Otsuka A. Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors. Allergol. Int., 2022, vol. 71, no. 1, pp. 40–46. doi: 10.1016/j.alit.2021.10.004</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Okereke I.C., Miller A.L., Hamilton C.F., Booth A.L., Reep G.L., Andersen C.L., Reynolds S.T., Pyles R.B. Microbiota of the oropharynx and endoscope compared to the esophagus. Sci. Rep., 2019, vol. 9, no. 1: 10201. doi: 10.1038/s41598-019-46747-y</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Park Y.M., Lee S.Y., Kang M.J., Kim B.S., Lee M.J., Jung S.S., Yoon J.S., Cho H.J., Lee E., Yang S.I., Seo J.H., Kim H.B., Suh D.I., Shin Y.H., Kim K.W., Ahn K., Hong S.J. Imbalance of gut Streptococcus, Clostridium, and Akkermansia determines the natural course of atopic dermatitis in infant. Allergy Asthma Immunol. Res., 2020, vol. 12, no. 2, pp. 322–337. doi: 10.4168/aair.2020.12.2.322</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Pothmann A., Illing T., Wiegand C., Hartmann A.A., Elsner P. The microbiome and atopic dermatitis: a review. Am. J. Clin. Dermatol., 2019, vol. 20, no. 6, pp. 749–761. doi: 10.1007/s40257-019-00467-1</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Santamaria-Babí L.F. Atopic dermatitis pathogenesis: lessons from immunology. Dermatol. Pract. Concept., 2022, vol. 12, no. 1: e2022152. doi: 10.5826/dpc.1201a152</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Schuler CF 4th, Billi A.C., Maverakis E., Tsoi L.C., Gudjonsson J.E. Novel insights into atopic dermatitis. J. Allergy Clin. Immunol., 2023, vol. 151, no. 5, pp. 1145–1154. doi: 10.1016/j.jaci.2022.10.023</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Thorsen J., Stokholm J., Rasmussen M.A., Roggenbuck-Wedemeyer M., Vissing N.H., Mortensen M.S., Brejnrod A.D., Fleming L., Bush A., Roberts G., Singer F., Frey U., Hedlin G., Nordlund B., Murray C.S., Abdel-Aziz M.I., Hashimoto S., van Aalderen W., Maitland-van der Zee A.H., Shaw D., Fowler S.J., Sousa A., Sterk P.J., Chung K.F., Adcock I.M., Djukanovic R., Auffray C., Bansal A.T., Wagers S., Chawes B., Bønnelykke K., Sørensen S.J., Bisgaard H. Asthma and wheeze severity and the oropharyngeal microbiota in children and adolescents. Ann. Am. Thorac. Soc., 2022, vol. 19, no. 12, pp. 2031–2043. doi: 10.1513/AnnalsATS.202110-1152OC</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Xue Y., Zhang L., Chen Y., Wang H., Xie J. Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study. Front. Med., 2023, no. 10: 1174331. doi: 10.3389/fmed.2023.1174331</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Yang W., Dong H.P., Wang P., Xu Z.G., Xian J., Chen J., Wu H., Lou Y., Lin D., Zhong B. IL-36γ and IL-36Ra reciprocally regulate colon inflammation and tumorigenesis by modulating the cell-matrix adhesion network and wnt signaling. Adv. Sci. (Weinh)., 2022, vol. 9, no. 10: e2103035. doi: 10.1002/advs.202103035</mixed-citation></ref></ref-list></back></article>
